Skip to main content
Erschienen in: Clinical Rheumatology 9/2020

27.03.2020 | Original Article

Early onset primary Sjögren syndrome, clinical and laboratory characteristics

verfasst von: Müçteba Enes Yayla, Zehra Karaman, Murat Torgutalp, Ayşe Bahar Keleşoğlu Dinçer, Emine Gözde Aydemir Gülöksüz, Serdar Sezer, Didem Şahin Eroğlu, Mehmet Levent Yüksel, Tahsin Murat Turgay, Gülay Kınıklı, Aşkın Ateş

Erschienen in: Clinical Rheumatology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction/objectives

Primary Sjögren syndrome (pSS) is usually encountered between the fourth and sixth decades. It is known that the age of onset in autoimmune diseases may affect the clinical features. In this study, we aimed to investigate the clinical and laboratory characteristics of early onset pSS patients.

Method

The data of 352 pSS patients were analyzed retrospectively. The patients were divided into two groups as those with the onset age of 35 or younger (early-onset) and those with the onset age of older than 35. The clinical, laboratory, and serological characteristics of the two groups were compared. p < 0.05 was considered statistically significant.

Results

Forty patients in the group with an onset age of 35 or younger (11.4%) and 312 patients with an onset age of older than 35 (88.6%) were analyzed. The frequency of skin (22.5% vs 1.9%, p < 0.001) and renal involvement (10% vs 2.2%, p = 0.026) was significantly higher in the early-onset group than the late-onset group. There was no significant difference between the two groups in terms of xerostomia, eye dryness, arthritis, and other systemic involvement. Anti-Ro52 positivity (p = 0.04), elevated serum IgG levels (p = 0.004), and low C4 (p = 0.002) presence were more frequent in the early-onset group.

Conclusions

Consequently, it is seen that the clinical phenotype of early-onset pSS patients may be different to those with later onset. Especially the more frequent observation of poor prognostic factors at early-onset ages shows the necessity to monitor these patients more regularly.
Key points:
• The clinical and laboratory features of patients with early-onset primary Sjogren syndrome may differ from late-onset patients.
Literatur
1.
Zurück zum Zitat Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sjögren’s syndrome. Autoimmun Rev 9(5):A305–A310CrossRef Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sjögren’s syndrome. Autoimmun Rev 9(5):A305–A310CrossRef
2.
Zurück zum Zitat Jülich M, Kanne A-M, Sehnert B, Budweiser S, Voll RE, Kollert F (2018) Serological lymphocytic activity and patient-reported outcomes in Sjögren’s syndrome. Clin Rheumatol 37(9):2361–2366CrossRef Jülich M, Kanne A-M, Sehnert B, Budweiser S, Voll RE, Kollert F (2018) Serological lymphocytic activity and patient-reported outcomes in Sjögren’s syndrome. Clin Rheumatol 37(9):2361–2366CrossRef
3.
Zurück zum Zitat Singh AG, Singh S, Matteson EL (2015) Rate, risk factors and causes of mortality in patients with Sjögren’s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology 55(3):450–460PubMed Singh AG, Singh S, Matteson EL (2015) Rate, risk factors and causes of mortality in patients with Sjögren’s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology 55(3):450–460PubMed
4.
Zurück zum Zitat Ramos-Casals M, Font J (2005) Primary Sjogren’s syndrome: current and emergent aetiopathogenic concepts. Rheumatology 44(11):1354–1367CrossRef Ramos-Casals M, Font J (2005) Primary Sjogren’s syndrome: current and emergent aetiopathogenic concepts. Rheumatology 44(11):1354–1367CrossRef
5.
Zurück zum Zitat Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 58(1):15–25CrossRef Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 58(1):15–25CrossRef
6.
Zurück zum Zitat Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 164(12):1275–1284CrossRef Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 164(12):1275–1284CrossRef
7.
Zurück zum Zitat Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G (2012) How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis 2012 Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G (2012) How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis 2012
8.
Zurück zum Zitat Ramos-Casals M, Cervera R, Font J, Garcóa-Carrasco M, Espinosa G, Reino S, Pallares L, Ingelmo M (1998) Young onset of primary Sjögren’s syndrome: clinical and immunological characteristics. Lupus 7(3):202–206CrossRef Ramos-Casals M, Cervera R, Font J, Garcóa-Carrasco M, Espinosa G, Reino S, Pallares L, Ingelmo M (1998) Young onset of primary Sjögren’s syndrome: clinical and immunological characteristics. Lupus 7(3):202–206CrossRef
9.
Zurück zum Zitat Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, Font J, Ingelmo M (2002) Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 81(4):270–280CrossRef Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, Font J, Ingelmo M (2002) Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 81(4):270–280CrossRef
10.
Zurück zum Zitat Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, Calvo-Alen J, Jiménez-Alonso J, Micó M-L, Beltrán J (2008) Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 87(4):210–219CrossRef Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, Calvo-Alen J, Jiménez-Alonso J, Micó M-L, Beltrán J (2008) Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 87(4):210–219CrossRef
11.
Zurück zum Zitat Tishler M, Yaron I, Shirazi I, Yaron M (2001) Clinical and immunological characteristics of elderly onset Sjögren’s syndrome: a comparison with younger onset disease. J Rheumatol 28(4):795–797PubMed Tishler M, Yaron I, Shirazi I, Yaron M (2001) Clinical and immunological characteristics of elderly onset Sjögren’s syndrome: a comparison with younger onset disease. J Rheumatol 28(4):795–797PubMed
12.
Zurück zum Zitat Botsios C, Furlan A, Ostuni P, Sfriso P, Andretta M, Ometto F, Raffeiner B, Todesco S, Punzi L (2011) Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 78(2):171–174CrossRef Botsios C, Furlan A, Ostuni P, Sfriso P, Andretta M, Ometto F, Raffeiner B, Todesco S, Punzi L (2011) Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 78(2):171–174CrossRef
13.
Zurück zum Zitat Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35–45CrossRef Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35–45CrossRef
14.
Zurück zum Zitat Aljohani R, Gladman D, Su J, Urowitz M (2017) Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus 26(11):1190–1196CrossRef Aljohani R, Gladman D, Su J, Urowitz M (2017) Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus 26(11):1190–1196CrossRef
15.
Zurück zum Zitat Tucker L, Uribe A, Fernandez M, Vila L, McGwin G, Apte M, Fessler B, Bastian H, Reveille J, Alarcón G (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17(4):314–322CrossRef Tucker L, Uribe A, Fernandez M, Vila L, McGwin G, Apte M, Fessler B, Bastian H, Reveille J, Alarcón G (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17(4):314–322CrossRef
16.
Zurück zum Zitat Carreira PE, Carmona L, Joven B, Loza E, Andréu J, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker U (2019) Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scand J Rheumatol 48(1):42–51CrossRef Carreira PE, Carmona L, Joven B, Loza E, Andréu J, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker U (2019) Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scand J Rheumatol 48(1):42–51CrossRef
17.
Zurück zum Zitat Anquetil C, Hachulla E, Machuron F, Mariette X, Le Guern V, Vittecoq O, Dernis E, Larroche C, Dubost J-J, Perdriger A (2019) Is early-onset primary Sjögren’s syndrome a worse prognosis form of the disease? Rheumatology 58(7):1163–1167CrossRef Anquetil C, Hachulla E, Machuron F, Mariette X, Le Guern V, Vittecoq O, Dernis E, Larroche C, Dubost J-J, Perdriger A (2019) Is early-onset primary Sjögren’s syndrome a worse prognosis form of the disease? Rheumatology 58(7):1163–1167CrossRef
Metadaten
Titel
Early onset primary Sjögren syndrome, clinical and laboratory characteristics
verfasst von
Müçteba Enes Yayla
Zehra Karaman
Murat Torgutalp
Ayşe Bahar Keleşoğlu Dinçer
Emine Gözde Aydemir Gülöksüz
Serdar Sezer
Didem Şahin Eroğlu
Mehmet Levent Yüksel
Tahsin Murat Turgay
Gülay Kınıklı
Aşkın Ateş
Publikationsdatum
27.03.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 9/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05017-3

Weitere Artikel der Ausgabe 9/2020

Clinical Rheumatology 9/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.